Responses
Clinical/translational cancer immunotherapy
Original research
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
